Literature DB >> 18364668

The role of serum vascular endothelial growth factor and matrix metalloproteinase-9 in predicting response to chemotherapy in patients with advanced nonsmall cell lung cancer.

Aziz Yazar, Hilal Soydinc, Esra Ertan, Vildan Yasasever, Faruk Tas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18364668     DOI： 10.1097/SMJ.0b013e318164e432

Source DB:  PubMed          Journal:  South Med J        ISSN： 0038-4348            Impact factor:   0.954


× No keyword cloud information.
  2 in total

1.  Elevated serum levels of vascular endothelial growth factor predict a poor prognosis of platinum-based chemotherapy in non-small cell lung cancer.

Authors:  Jialan Zang; Yong Hu; Xiaoyue Xu; Jie Ni; Dali Yan; Siwen Liu; Jieyu He; Jing Xue; Jianzhong Wu; Jifeng Feng
Journal:  Onco Targets Ther       Date:  2017-01-18       Impact factor: 4.147

2.  Sequential measurements of serum matrix metalloproteinase 9 to monitor chemotherapy responses in patients with advanced non-small-cell lung cancer.

Authors:  Xiaojuan Qiao; Xiaoran Zhai; Jinghui Wang; Xiaoting Zhao; Xinjie Yang; Jialin Lv; Li Ma; Lina Zhang; Yue Wang; Shucai Zhang; Wentao Yue
Journal:  Onco Targets Ther       Date:  2016-06-01       Impact factor: 4.147
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.